ARCHIVES

NCI-Approved Clinical Trials Listed For January

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Issues Statement On Endostatin Research

October 1, 1999

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010

Foundation For COG Is New Name Of NCCF.

October 19, 2001

Avastin Improves PFS For Metastatic Colorectal Cancer In Phase III Study

February 23, 2007

DCT Board Approves Concept Of Contract Recompetitions Worth $5.1 Million A Year

July 10, 1981

In Brief : Three Named To Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

July 11, 2014